{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-004554","form_type":"8-K","ticker":"GNLX","cik":"0001231457","company_name":"GENELUX Corp","filed_at":"2025-02-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.134674+00:00","generated_at":"2026-05-27T03:55:08.804805+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Genelux CFO Lourie Zak resigns; Matt Pulisic appointed CFO with $410k salary, 275k option","bullets":["Lourie Zak resigned as CFO effective Jan 29, 2025; separation includes $180k cash payment (6 months salary) and advisory role through Aug 29, 2025.","Matt Pulisic appointed CFO effective Jan 30, 2025; previously VP Finance at Arrowhead Pharmaceuticals.","Pulisic receives base salary of $410,000/year, target bonus of 40% of base, and option to purchase 275,000 shares at $3.95/share.","Option vests over 4 years (25% after one year, then monthly); full acceleration upon change in control.","Pulisic eligible for severance: 6 months base salary without cause, 12 months base salary if termination within change in control period."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-004554","json":"https://secwatch.observer/filing/0001493152-25-004554.json","markdown":"https://secwatch.observer/filing/0001493152-25-004554.md","text":"https://secwatch.observer/filing/0001493152-25-004554.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/0001493152-25-004554-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T03:55:08.804805+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9eac72b8fd","claim":"Matt Pulisic was appointed as Chief Financial Officer at GENELUX Corp.","evidence_excerpt":"On February 3, 2025, the Company announced the appointment of Matt Pulisic as the Company’s Chief Financial Officer, effective as of January 30, 2025 (the “ Effective Date ”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/0001493152-25-004554-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}]},{"claim_id":"daab59e0a8","claim":"Lourie Zak resigned as Chief Financial Officer at GENELUX Corp.","evidence_excerpt":"On January 29, 2025 (the “ Separation Date ”), Lourie Zak resigned as Chief Financial Officer of Genelux Corporation (the “ Company ”), effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1231457/000149315225004554/0001493152-25-004554-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}